DOH: Some 690,000 immunocompromised individuals can receive 2nd booster | ABS-CBN

ABS-CBN Ball 2025:
|

ADVERTISEMENT

ABS-CBN Ball 2025:
|
dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

DOH: Some 690,000 immunocompromised individuals can receive 2nd booster

DOH: Some 690,000 immunocompromised individuals can receive 2nd booster

ABS-CBN News

Clipboard

iWantTFC

Watch more on iWantTFC.com. Watch hundreds of Pinoy shows, movies, live sports and news.

Watch more on iWantTFC.com. Watch hundreds of Pinoy shows, movies, live sports and news.

Video from PTV

MANILA – Some 690,000 adults with health risks are eligible to get a second COVID-19 booster shot, the Department of Health (DOH) said on Saturday.

Health Undersecretary Myrna Cabotaje said the agency was expected to immunize up to 13,000 people with comorbidities – the priority sector for this booster campaign – beginning on Monday.

Second booster shots will be administered at least three months after the first one, according to the health department.

"Ikakasa natin sa buong bansa, depende sa kahandaan ng ating mga bakuna center na mag-implement ng mga second booster," Cabotaje said in a public briefing.

ADVERTISEMENT

In a separate statement, the DOH defined immunocompromised individuals as having the following:

  • Immunodeficiency state
  • HIV
  • Active cancer or malignancy
  • Transplant recipients
  • Undergoing steroid treatment
  • Patients with poor prognosis or bed-ridden patients
  • Other conditions of immunodeficiency as certified by a physician

The Food and Drug Administration (FDA) approved the following vaccine brands for the second booster dose, DOH said:

  • AstraZeneca
  • Pfizer
  • Moderna
  • Sinovac
  • Sinopharm

Based on government data, the country has fully vaccinated some 67.1 million individuals, while about 12.7 million have received booster shots.

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.